|
|
General
|
| |
Clinical Use:
|
DHT is primarily responsible for the physical changes that occur during male sexual development and virilisation. Can be used to assess Disorders of Sex Development (DSD's). |
| |
Availability:
|
Samples are batched and tested twice a week. |
| |
Aliases/Synonyms:
| DHT, |
| |
Code:
|
DHT |
| |
Handling Instructions (to laboratory):
|
Send sample chilled. |
| |
Hyperlink:
|
|
| |
Reference Interval:
|
Male
0d to <7d 0.15-2.10
7d to <212d 0.40-2.95
212d to <10y <0.20
10y to <20y <1.85
20y to <120y 0.35-2.50
Female
0d to <7d <0.50
7d to <10y <0.20
10y to <20y 0.15-0.60
20y to <120y 0.10-0.70
Ref - ARUP Laboratories.
|
Collection Requirements
|
| |
Container:
|
Serum, no gel (RED), |
| |
Sample Type:
|
See container |
| |
Minimum Collection Volume:
|
300uL |
| |
Collection Instructions:
|
|
Processing Requirements
|
| |
Alternate Containers:
|
|
| |
Processing Instructions:
|
If a sample other than serum non-gel is received, please forward sample to the testing department to determine sample suitability.
For requests received at FSH, RPH or Fremantle please consult with the Duty Biochemist before proceeding with registration of the request. |
| |
Minimum Assay Volume:
|
|
| |
Stability:
|
2 weeks chilled; 6 months frozen |
| |
Transport Instructions (to testing laboratory):
|
Send sample chilled. |
Testing Locations
|
| |
Performed at:
|
|
Section
|
Department
|
Site
|
Contact Phone
|
| Special Chemistry |
Biochemistry |
QEII Medical Centre |
6383 4114 |
|
Last Updated : 06-10-2020 09:41 |